Summary of Best Evidence for Wound Management in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0511Keywords:
evidence-based practice, Stevens-Johnson syndrome, toxic epidermal necrolysis, wound healing, skin careAbstract
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threate-ning mucocutaneous reactions characterized by extensive epidermal detachment and systemic complications. Wound management is central to survival and long-term outcomes, yet standardiz-ed care pathways remain controversial and in-consistently implemented. This study aimed to systematically synthesize the best available evidence on wound management for patients with SJS/TEN to support clinical decision-making and optimize clinical outcomes. A comprehensive search of major international and Chinese databases and authoritative websites was conducted from January 2010 to May 2025 to collect relevant clinical decisions, guidelines, expert consensus, systematic reviews, and evidence summaries. Two reviewers independently screened and evaluated the literature, and then extracted and summarized evidence using the JBI grading system. A total of 14 high-quality publications met the inclusion criteria, yielding 28 pieces of best evidence across seven7 domains: wound assessment, conservative management, surgical approach, dressing selection, pain management, infection prevention and surveillance, and hospital setting. Among them, 11 recommendations were graded as strong and 17 as weak. This evidence-based synthesis provides practical guidance for wound management in SJS/TEN and supports the development of standardized care protocols to promote epithelial recovery, reduce complications, and improve quality of life.
Downloads
References
Chaby G, Maldini C, Haddad C, Lebrun-Vignes B, Hemery F, Ingen-Housz-Oro S, et al. Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-16: a four-source capture-recapture estimate. Br J Dermatol 2020; 182: 618–624. DOI: https://doi.org/10.1111/bjd.18424
Yang MS, Lee JY, Kim J, Kim GW, Kim BK, Kim JY, et al. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study usA Nationwide Population-Based Study Using National Health Insurance Database in Korea. PLoS ONE 2016; 11: e0165933. DOI: https://doi.org/10.1371/journal.pone.0165933
White KD, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard C, Carleton B, et al. SJS/TEN 2017: Building multidisciplinary networks to drive science and translation. J Allergy Clin Immunol Pract 2018; 6: 38–69. DOI: https://doi.org/10.1016/j.jaip.2017.11.028
The Chinese Medical Association Dermatology and Venereology Branch Drug Adverse Reaction Research Center. Expert consensus on the diagnosis and treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis. Chin J Dermatol 2021; 54: 376–381.
McPherson T, Exton LS, Biswas S, Creamer D, Dziewulski P, Newell L, et al. British association of Dermatologists’ guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018. Br J Dermatol 2019; 181: 37–54. DOI: https://doi.org/10.1111/bjd.17841
Lee JS, Mallitt K, Fischer G, Saunderson RB. An individual patient data meta-analysis of wound care in patients with toxic epidermal necrolysis. Australas J Dermatol 2024; 65: 128–142. DOI: https://doi.org/10.1111/ajd.14193
Hanson LM, Bettencourt AP. Stevens-Johnson syndrome and toxic epidermal necrolysis: A guide for nurses. AACN Adv Crit Care 2020; 31: 281–295. DOI: https://doi.org/10.4037/aacnacc2020634
Charlton OA, Harris V, Phan K, Mewton E, Jackson C, Cooper A. Toxic Epidermal Necrolysis and Steven–Johnson Syndrome: A comprehensive review. Adv Wound Care 2020; 9: 426–439. DOI: https://doi.org/10.1089/wound.2019.0977
BI Manual for Evidence Synthesis. [cited 2026 February 28]. Available from: https://jbi-global-wiki.refined.site/space/jbi-global-wiki.refined.site
Cheng L, Feng S, Hu Y. Evidence-based nursing implementation in Mainland China: A scoping review. Nurs Outlook 2017; 65: 27–35. DOI: https://doi.org/10.1016/j.outlook.2016.07.016
DiCenso A, Bayley L, Haynes RB. ACP Journal Club. Editorial: Accessing preappraised evidence: fine-tuning the 5S model into a 6S model. Ann Intern Med 2009; 151: JC3–2. DOI: https://doi.org/10.7326/0003-4819-151-6-200909150-02002
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J 2010; 182: E839–E842. DOI: https://doi.org/10.1503/cmaj.090449
Zhang L, Xiao-Bing F, Chen S, Zhao ZB, Schmitz C, Weng CS. Efficacy and safety of extracorporeal shock wave therapy for acute and chronic soft tissue wounds: A systematic review and meta-analysis. Int Wound J 2018; 15: 590–599. DOI: https://doi.org/10.1111/iwj.12902
Joanna Briggs Institute. Checklist for text and opinion—Critical Appraisal tools for use in JBI Systematic Reviews. 2020. [cited 2026 May 5]. Available from: https://jbi.global/sites/default/files/2020-08/Checklist_for_Text_and_Opinion.pdf
Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med 2016; 15: 155–163. DOI: https://doi.org/10.1016/j.jcm.2016.02.012
Wang CQ, Hu Y. JBI evidence hierarchy and evidence recommendation classification system(2014).Journal of Nurses Training. J Nurses Train 2015; 30: 964–967.
Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JKG, et al. U.K. guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016. Br J Dermatol 2016; 174: 1194–1227. DOI: https://doi.org/10.1111/bjd.14530
Mahar PD, Wasiak J, Hii B, Cleland H, Watters DA, Gin D, et al. A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres. Burns 2014; 40: 1245–1254. DOI: https://doi.org/10.1016/j.burns.2014.02.006
Castillo B, Vera N, Ortega-Loayza AG, Seminario-Vidal L. Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis. J Am Acad Dermatol 2018; 79: 764–767. DOI: https://doi.org/10.1016/j.jaad.2018.03.032
French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int 2006; 55: 9–16. DOI: https://doi.org/10.2332/allergolint.55.9
Paulmann M, Heuer R, Annecke T, Behr B, Boch K, Boos AM, et al. S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens‐Johnson syndrome and toxic epidermal necrolysis) – Part 2: Supportive therapy of EN in the acute and post‐acute stages. J Deutsche Derma Gesell 2024; 22: 1576–1593. DOI: https://doi.org/10.1111/ddg.15516
Kowal-Vern A. Stevens-johnson syndrome and toxic epidermal necrolysis - symptoms, diagnosis and treatment | BMJ best practice. . [cited 2025 April 17]. Available from: https://bestpractice.bmj.com/topics/en-gb
Ingen-Housz-Oro S, Duong TA, Bensaid B, Bellon N, de Prost N, Lu D, et al. Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins). Orphanet J Rare Dis 2018; 13: 56. DOI: https://doi.org/10.1186/s13023-018-0793-7
Seminario-Vidal L, Kroshinsky D, Malachowski SJ, Sun J, Markova A, Beachkofsky TM, et al. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults. J Am Acad Dermatol 2020; 82: 1553–1567. DOI: https://doi.org/10.1016/j.jaad.2020.02.066
Gupta LK, Martin AM, Agarwal N, D’Souza P, Das S, Kumar R, et al. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective. Indian J Dermatol Venereol Leprol 2016; 82: 603–625. DOI: https://doi.org/10.4103/0378-6323.191134
Schneider JA, Cohen PR. Stevens-Johnson syndrome and toxic epidermal necrolysis: A concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures. Adv Ther 2017; 34: 1235–1244. DOI: https://doi.org/10.1007/s12325-017-0530-y
Castillo B, Vera N, Ortega-Loayza AG, Seminario-Vidal L. Reply to: “Wound management strategies in Stevens-Johnson syndrome/toxic epidermal necrolysis: An unmet need”. J Am Acad Dermatol 2018; 79: e89. DOI: https://doi.org/10.1016/j.jaad.2018.06.017
Brüggen MC, Le ST, Walsh S, Toussi A, de Prost N, Ranki A, et al. Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus. Br J Dermatol 2021; 185: 616–626. DOI: https://doi.org/10.1111/bjd.19893
Huang SH, Yang PS, Wu SH, Chang KP, Lin TM, Lin SD, et al. Aquacel Ag with Vaseline gauze in the management of toxic epidermal necrolysis (TEN). Burns 2010; 36: 121–126. DOI: https://doi.org/10.1016/j.burns.2009.02.018
O’Donohoe PK, Leon R, Orr DJA, de Blacam C. Safety of silver dressings in infants; a systematic scoping review. J Burn Care Res 2025; 46: 349–360. DOI: https://doi.org/10.1093/jbcr/irae159
Lee HY. Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae - UpToDate. [cited 2025 May 5]. Available from: https://sso.uptodate.com/contents/zh-Hans/stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-management-prognosis-and-long-term-sequelae
Boorboor P, Vogt PM, Bechara FG, Alkandari Q, Aust M, Gohritz A, et al. Toxic epidermal necrolysis: Use of Biobrane® for skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients. Burns 2008; 34: 487–492. DOI: https://doi.org/10.1016/j.burns.2007.06.008
Rogers AD, Blackport E, Cartotto R. The use of Biobrane ® for wound coverage in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis. Burns 2017; 43: 1464–1472. DOI: https://doi.org/10.1016/j.burns.2017.03.016
Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008; 14: 1343–1350. DOI: https://doi.org/10.1038/nm.1884
Noe MH, Micheletti RG. Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis. Clin Dermatol 2020; 38: 607–612. DOI: https://doi.org/10.1016/j.clindermatol.2020.06.016
Żwierełło W, Piorun K, Skórka-Majewicz M, Maruszewska A, Antoniewski J, Gutowska I. Burns: Classification, Pathophysiology, and Treatment: A Review. Int J Mol Sci 2023; 24: 3749. DOI: https://doi.org/10.3390/ijms24043749
Yang C, Xu XM, He GZ. Efficacy and feasibility of opioids for burn analgesia: An evidence-based qualitative review of randomized controlled trials. Burns 2018; 44: 241–248. DOI: https://doi.org/10.1016/j.burns.2017.10.012
Lipový B, Holoubek J, Hanslianová M, Cvanová M, Klein L, Grossová I, et al. Toxic epidermal necrolysis data from the CELESTE multinational registry. Part I: Epidemiology and general microbiological characteristics. Burns 2018; 44: 1551–1560. DOI: https://doi.org/10.1016/j.burns.2018.01.019
Kim HI, Kim SW, Park GY, Kwon EG, Kim HH, Jeong JY, et al. Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients. Korean J Intern Med 2012; 27: 203–210. DOI: https://doi.org/10.3904/kjim.2012.27.2.203
World Health Organization. Prevention and management of wound infection. 2013. [cited 2025 May 5]. Available from: https://www.who.int/publications/i/item/prevention-and-management-of-wound-infection
Additional Files
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
